Subscribe to our Newsletters !!
Fermentation is a natural method which is applied
In the world of Biochemistry, Microbiology and Pha
The human metapneumovirus, more simply referred to
Indegene, a digital-first life sciences commercial
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of The Magazine
New Delhi: Drug company Strides Pharma Science on Friday said its subsidiary, Strides Pharma International Pte Ltd, has received approval from the US health regulator for Prednisone pills , prescribed for a variety of conditions, such as allergies, respiratory disease and arthritis. Strides Pharma Global Pte Limited, Singapore, has obtained approval for Prednisone tablets USP in the strengths of 10 mg and 20 mg from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.
Prednisone is a member of a class of drugs known as corticosteroids and is used as an anti-inflammatory or an immuno-suppressant medication. It’s used in treatment of different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or respiratory disorders.
Quoting IQVIA MAT December 2020 data, Strides Pharma Science reported the US market for Prednisone tablets USP, 10 mg and 20 mg is approximately USD 60 million.
The product will be manufactured at the company’s facility at Bengaluru and will be promoted by Strides Pharma Inc in the US market.
The business has 127 cumulative abbreviated new drug application (ANDA) filings with USFDA of which 98 ANDAs are approved and 29 are pending for approval.
Shares of Strides Pharma Science were trading 2.81 per cent higher at Rs 890.10 apiece on BSE.
